The Tamiflu Trials: Profit and Public Health

episode

New Books in Public Policy not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from New Books in Public Policy

Michelle Adams, "The Containment: Detroit, the Supreme Court, and the Battle for Racial Justice in the North " (FSG, 2025) 1h 5m · 09 Sep 2026

All episodes from New Books in Public Policy →

Report any issue

Source

Recorded02 Sep 2022

Publisherfeeds.megaphone.fm

Handlerec:5318298

Show notes

Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, governments spent billions stockpiling this drug called Tamiflu. You’d think governments used the best evidence-based advice, but the story of Tamiflu raises questions about how money shaped the process. On this episode of Cited, Darts and Letters predecessor, we open up the black box of pharmaceutical and public health expertise. We tell the story of a drug, from its days as middling flu treatment through its meteoric rise to international blockbuster. How do experts decide what makes a good drug, and how do pharmaceutical companies make billions from pandemic panic? —————————-SUPPORT THE SHOW—————————- You can support the show for free by following or subscribing on Spotify, Apple Podcasts, or whichever app you use. This is the best way to help us out and it costs nothing so we’d really appreciate you clicking that button. If you want to do a little more we would love it if you chip in. You can find us on patreon.com/dartsandletters. Patrons get content early, and occasionally there’s bonus material on there too. ——————-ABOUT THE SHOW—————— For a full list of credits, contact information, and more, visit our about page. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/public-policy

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.